Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for Pulmonary Embolism
55 locations incl. Long Beach
Sponsor: Penumbra Inc.
Sex: All·Age: 18+
Code: NCT04798261·Recruiting·Listed Mar 2021
Staten Island University Hospital Northwell Health
Clinical research site in Staten Island, New York · 475 SEAVIEW AVE, STATEN ISLAND, NY 10305-3436 · (718) 226-4502
As of July 2026, 15 paid clinical trials are recruiting at Staten Island University Hospital Northwell Health in Staten Island, New York. Active studies at this site cover conditions such as Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 and Anatomic Stage IIIA Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Staten Island University Hospital Northwell Health (15)
Pivotal Study of the Velocity™ pAVF System
for Chronic Kidney Disease
12 locations incl. Dothan
Sponsor: Venova Medical
Sex: All·Age: 18 - 80
Code: NCT07153939·Recruiting·Listed Sep 2025
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
for Chronic Limb-Threatening Ischemia
3 locations incl. New York
Sponsor: R3 Vascular Inc.
Sex: All·Age: 18+
Code: NCT06071429·Recruiting·Listed Oct 2023
Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction
for Atrial Fibrillation
6 locations incl. Bay Shore
Sponsor: Northwell Health
Sex: All·Age: 18+
Code: NCT07638995·Recruiting·Listed Jun 10, 2026
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
for Advanced Endometrial Carcinoma
228 locations incl. Virginia
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18+
Code: NCT07198074·Phase 3·Recruiting·Listed Sep 2025
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
for Breast Cancer
1105 locations incl. Anchorage
Sponsor: NRG Oncology
Sex: Female·Age: 18 - 60
Code: NCT05879926·Phase 3·Recruiting·Listed May 2023
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
for Stage III Colon Cancer
922 locations incl. Fairhope
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05174169·Phase 2, Phase 3·Recruiting·Listed Dec 2021
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
for Anatomic Stage II Breast Cancer AJCC v8
776 locations incl. Fairhope
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT05812807·Phase 3·Recruiting·Listed Apr 2023
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for Anatomic Stage I Breast Cancer AJCC v8
585 locations incl. Phoenix
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT06876714·Phase 3·Recruiting·Listed Mar 2025
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for Anatomic Stage II Breast Cancer AJCC v8
525 locations incl. Birmingham
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06058377·Phase 3·Recruiting·Listed Sep 2023
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
for Locally Advanced Lung Non-Small Cell Carcinoma
446 locations incl. Birmingham
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05624996·Phase 3·Recruiting·Listed Nov 2022
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
for Stage I Breast Cancer
707 locations incl. Mobile
Sponsor: NRG Oncology
Sex: All·Age: 50 - 70
Code: NCT04852887·Phase 3·Recruiting·Listed Apr 2021
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for Atrial Fibrillation
87 locations incl. Phoenix
Sponsor: Johns Hopkins University
Sex: All·Age: 22 - 85
Code: NCT05836987·Phase 3·Recruiting·Listed May 2023
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
for Anatomic Stage I Breast Cancer AJCC v8
915 locations incl. Birmingham
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT05929768·Phase 3·Recruiting·Listed Jul 2023
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
for Nasal Obstruction
3 locations incl. Poplar Bluff
Sponsor: Northwell Health
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT05287841·Recruiting·Listed Mar 2022
More research sites in Staten Island
- Staten Island University Hospital (13 trials)
- Richmond Behavioral Associates (11 trials)
- Richmond University Medical Center (6 trials)
- Northwell Health (2 trials)
- Northwell Health- Staten Island University Hospital (2 trials)
- Seaport Investigator Site (2 trials)
- Vanda Investigational Site (2 trials)
- Autobahn (1 trial)
- College of Staten Island (Building 5N-218) (1 trial)
- Evolution Research Group (1 trial)
Explore more
Paid clinical trials in Staten Island, NY · New York clinical trials